نتایج جستجو برای: chronic myelogenous leukemia cml

تعداد نتایج: 730268  

2003
J. P.

Fluorescence in situ hybridization (FISH) has become an increasingly important method for assessing chromosome rearrangement. The reciprocal translocation constituting the Philadelphia (Ph) chromosome [t(9;22)(q34;q 1 1 )]characterizes more than 90% of patients with chronic myelogenous leukemia (CML). However, in the remaining cases the Ph chromosome (genetically characterized by the fusion of ...

Journal: :Cancer research 2003
Chi Ly Adrian F Arechiga Junia V Melo Craig M Walsh S Tiong Ong

Identification of signaling pathways downstream of Abl tyrosine kinase may increase our understanding of the pathogenesis of chronic myelogenous leukemia (CML) and suggest strategies to improve clinical treatment of the disease. By combining the use of a phosphospecific antibody recognizing a substrate motif of serine/threonine kinases with bioinformatics, we found that the translational regula...

2003
Chi Ly Adrian F. Arechiga Junia V. Melo Craig M. Walsh S. Tiong Ong

Identification of signaling pathways downstream of Abl tyrosine kinase may increase our understanding of the pathogenesis of chronic myelogenous leukemia (CML) and suggest strategies to improve clinical treatment of the disease. By combining the use of a phosphospecific antibody recognizing a substrate motif of serine/threonine kinases with bioinformatics, we found that the translational regula...

Journal: :Blood 2013
Christopher J Walker Joshua J Oaks Ramasamy Santhanam Paolo Neviani Jason G Harb Gregory Ferenchak Justin J Ellis Yosef Landesman Ann-Kathrin Eisfeld Nash Y Gabrail Carrie L Smith Michael A Caligiuri Peter Hokland Denis Claude Roy Alistair Reid Dragana Milojkovic John M Goldman Jane Apperley Ramiro Garzon Guido Marcucci Sharon Shacham Michael G Kauffman Danilo Perrotti

As tyrosine kinase inhibitors (TKIs) fail to induce long-term response in blast crisis chronic myelogenous leukemia (CML-BC) and Philadelphia chromosome-positive (Ph(+)) acute lymphoblastic leukemia (ALL), novel therapies targeting leukemia-dysregulated pathways are necessary. Exportin-1 (XPO1), also known as chromosome maintenance protein 1, regulates cell growth and differentiation by control...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 1997
H M Kantarjian M Talpaz S O'Brien R Kurzrock J Gutterman M J Keating K B McCredie E J Freireich

The purpose of this study was to review the progress in clinical and translational research in chronic myelogenous leukemia (CML) over the past 20 years at M.D. Anderson Cancer Center. The CML database updating the clinical and basic research investigations was reviewed as the source of this report. Publications resulting from these investigations were summarized. The long-term results with int...

Journal: :American journal of hematology 2000
M Yasukawa H Ohminami K Kojima K Inokuchi Y Nishimura S Fujita

To clarify the association between HLA-DRB1 alleles and chronic myelogenous leukemia (CML), the HLA-DRB1 allele frequencies in 50 Japanese patients each with b2a2 and b3a2 CML and 127 healthy Japanese individuals were examined. In the patients with b2a2 CML, the frequencies of HLA-DRB1*0405, DRB1*08032, and DRB1*1502 were low and that of HLA-DRB1*1201 was high in comparison with the healthy ind...

Journal: :Cancer research 1991
A S Fokas J B Keller B D Clarkson

We present a mathematical model of granulocytopoiesis that depends on certain physiologically meaningful parameters. By choosing different values of these parameters, the model describes both the normal process and that in chronic myelogenous leukemia (CML). The model fits all the available experimental data tested. Furthermore, it shows how the CML cells can ultimately outnumber the normal cel...

2005
Emil J Freireich Hagop M. Kantarjian Moshe Talpaz Susan O’Brien Razelle Kurzrock Jordan Gutterman Michael J. Keating Kenneth B. McCredie M. D. Anderson

The purpose of this study was to review the progress in clinical and translational research in chronic myelogenous leukemia (CML) over the past 20 years at M. D. Anderson Cancer Center. The CML database updating the clinical and basic research investigations was reviewed as the source of this report. Publications resulting from these investigations were summarized. The long-term results with in...

Journal: :Blood 2005
Michael W N Deininger Tessa L Holyoake

In patients with chronic myelogenous leukemia (CML) mutations of the BCR-ABL kinase domain (KD) have been identified as the leading cause of acquired resistance to imatinib, while the mechanisms underlying the persistence of minimal residual disease (MRD) are unknown. In this issue of Blood, Chu and colleagues report several patients with KD mutations at the time of complete cytogenetic respons...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2012
Ann Cai Derin B Keskin David S DeLuca Anselmo Alonso Wandi Zhang Guang Lan Zhang Naa Norkor Hammond Valentina Nardi Richard M Stone Donna Neuberg John Sidney Vladimir Brusic Catherine J Wu

PURPOSE Characterization of an approach to identify leukemia neoantigens arising in the context of drug resistance. EXPERIMENTAL DESIGN We assessed whether leukemia neoantigens could be generated from drug-resistant mutations in BCR-ABL after imatinib relapse in patients with chronic myelogenous leukemia (CML). RESULTS We computationally predicted that approximately 70 peptides derived from...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید